| Type 1 Excludes |
| appetite depressants (T50.5-) |
| barbiturates (T42.3-) |
| benzodiazepines (T42.4-) |
| methaqualone (T42.6-) |
| psychodysleptics [hallucinogens] (T40.7-T40.9-) |
| Type 2 Excludes |
| drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.- -F19.-) |
|
T43.0 |
Poisoning by, adverse effect of and underdosing of tricyclic and tetracyclic antidepressants |
|
T43.1 |
Poisoning by, adverse effect of and underdosing of monoamine-oxidase-inhibitor antidepressants |
|
T43.2 |
Poisoning by, adverse effect of and underdosing of other and unspecified antidepressants |
|
T43.3 |
Poisoning by, adverse effect of and underdosing of phenothiazine antipsychotics and neuroleptics |
|
T43.4 |
Poisoning by, adverse effect of and underdosing of butyrophenone and thiothixene neuroleptics |
|
T43.5 |
Poisoning by, adverse effect of and underdosing of other and unspecified antipsychotics and neuroleptics |
|
T43.6 |
Poisoning by, adverse effect of and underdosing of psychostimulants |
|
T43.8 |
Poisoning by, adverse effect of and underdosing of other psychotropic drugs |
|
T43.9 |
Poisoning by, adverse effect of and underdosing of unspecified psychotropic drug |
